SALEM INVESTMENT COUNSELORS INC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2020$80,000
-7.0%
10,000
-23.1%
0.01%
-37.5%
Q2 2019$86,000
-48.8%
13,0000.0%0.01%
-52.9%
Q1 2019$168,000
+60.0%
13,0000.0%0.02%
+30.8%
Q4 2018$105,000
-37.5%
13,0000.0%0.01%
-23.5%
Q3 2018$168,000
+13.5%
13,0000.0%0.02%
+21.4%
Q2 2018$148,000
+64.4%
13,0000.0%0.01%
+40.0%
Q1 2018$90,000
+5.9%
13,0000.0%0.01%
+11.1%
Q4 2017$85,000
+7.6%
13,0000.0%0.01%0.0%
Q3 2017$79,000
+41.1%
13,0000.0%0.01%
+50.0%
Q2 2017$56,000
-5.1%
13,0000.0%0.01%0.0%
Q1 2017$59,00013,0000.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders